Personal tools
Sections
You are here: Home Publications 2004 Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia
Document Actions

K J Anstrom, S D Reed, A S Allen, G A Glendenning, and K A Schulman (2004)

Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia

Up one level Last modified February 02, 2007 09:22 AM - EST

.

automatic medline import
 

This site conforms to the following standards: